Market Overview
According to fortune business insights, the global duodenoscopes market size was valued at USD 1.08 billion in 2025. The market is projected to grow from USD 1.16 billion in 2026 to USD 2.22 billion by 2034, exhibiting a CAGR of 8.4% during the forecast period. North America dominated the duodenoscopes market with a market share of 37.04% in 2025.
The analysis shows that top companies are investing more in duodenoscopes as the rising prevalence of gastrointestinal, biliary, and pancreatic disorders supports their adoption. The increasing use of Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures for therapeutic interventions is a key factor driving demand. This trend indicates strong growth for duodenoscopes worldwide.
Major Players Profiled in the Market Report:
Segments
Large Installed Bases to Propel Reusable Segment Growth
Based on product type, the market is divided into reusable and disposable. The reusable segment holds the largest market share owing to large existing installed bases, established reprocessing workflows, and trained endoscopy teams in high-volume ERCP centers.
Growing Use of ERCP for Treatment to Drive Therapeutic Segment Expansion
By application, the market is categorized into diagnostic and therapeutic. The therapeutic segment is leading the market due to the increasing shift of ERCP from a purely diagnostic procedure to a primary method for treating pancreaticobiliary diseases, such as performing stone extraction, stent placement, and drainage.
High Procedure Volume to Dominate Hospitals & ASCs Segment
Based on end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others. The hospitals & ASCs segment holds the largest market share as complex ERCP procedures require skilled gastroenterologists, fluoroscopy, anesthesia support, and emergency backup typically available in these settings.